Drug Profile, Expanded Targeted Panel by LC-MS/MS, Serum/Plasma

The drug screen panel can detect 127 drugs and drug metabolites by LC-MS/MS.  The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies within a drug class. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

This assay is for medical purposes only; not valid for forensic use

For a complete list of drugs and drug metabolites detected, refer to the Additional Technical Information.

This test was developed, and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.